(S)-3-(4-(2-Chloro-5-iodobenzyl)phenoxy)tetrahydrofuran
(S)-3-(4-(2-Chloro-5-iodobenzyl)phenoxy)tetrahydrofuran Basic information
- Product Name:
- (S)-3-(4-(2-Chloro-5-iodobenzyl)phenoxy)tetrahydrofuran
- Synonyms:
-
- (3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furan
- (S)-3-(4-(2-chloro-5-iodobenzyl)phenoxy)-tetrahydrofuran
- (S)-3-(4-(2-chloro-5-fluorobenzyl)phenoxy)-tetrahydrofuran
- EMpagliflozin iMpurity C
- (S)-4-iodo-1-chloro-2-(4-tetrahydrofuran-3-yloxy-benzyl)-benzene
- (3S)-3-{4-[(2-chloro-5-iodophenyl)methyl]phenoxy}oxolane
- (3S)-3-[4-(2-chloro-5-iodobenzyl)-phenoxy]-tetrahydrofuran
- Furan, 3-[4-[(2-chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-, (3S)-
- CAS:
- 915095-94-2
- MF:
- C17H16ClIO2
- MW:
- 414.67
- EINECS:
- 619-599-0
- Product Categories:
-
- Empagliflozin
- Empagliflozin Intermediate
- 915095-94-2
- Mol File:
- 915095-94-2.mol
(S)-3-(4-(2-Chloro-5-iodobenzyl)phenoxy)tetrahydrofuran Chemical Properties
- Boiling point:
- 476.0±45.0 °C(Predicted)
- Density
- 1.578±0.06 g/cm3 (20 ºC 760 Torr)
- storage temp.
- 2-8°C(protect from light)
- solubility
- DMSO, Methanol (Slightly, Sonicated)
- form
- Solid
- color
- White to Off-White
- InChI
- InChI=1S/C17H16ClIO2/c18-17-6-3-14(19)10-13(17)9-12-1-4-15(5-2-12)21-16-7-8-20-11-16/h1-6,10,16H,7-9,11H2/t16-/m0/s1
- InChIKey
- YLUHNGIWRCCQMQ-INIZCTEOSA-N
- SMILES
- O1CC[C@H](OC2=CC=C(CC3=CC(I)=CC=C3Cl)C=C2)C1
- CAS DataBase Reference
- 915095-94-2
(S)-3-(4-(2-Chloro-5-iodobenzyl)phenoxy)tetrahydrofuran Usage And Synthesis
Physical Form
Solid
Uses
(3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydrofuran(915095-94-2) can be used as reactant/reagent in preparation of C-?aryl D-?glurofuranoside compounds useful as reference compounds in the quality control of gliflozin type medicine.
Description
(S)-3-(4-(2-Chloro-5-iodobenzyl)phenoxy)tetrahydrofuran is a pharmaceutical intermediate compound that is used in the preparation of empagliflozin. Empagliflozin is an inhibitor of sodium-glucose co-transporter protein-2 (SGLT2), which is used in the treatment of type 2 diabetes.
Preparation
0.5 mol of (S)-(2-chloro-5-iodophenyl)(4-((tetrahydrofuran-3-yl)oxy)phenyl)methanone and 0.6 mol of aluminum chloride were added to 2 mol of methanol at a temperature of 20° C, and then 0.6 mol of triethylsilane was added to the mixed solution. The mixture was stirred at 25° C for 1 h.The conversion is determined by HPLC analysis. After the reaction is complete, it is extracted and distilled under reduced pressure.Finally, (3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furan (also known as (S)-3-(4-(2-Chloro-5-iodobenzyl)phenoxy)tetrahydrofuran) was obtained through purification.
(S)-3-(4-(2-Chloro-5-iodobenzyl)phenoxy)tetrahydrofuranSupplier
- Tel
- 0531-82371986 15064117275
- daisy@jndxj.com
- Tel
- 0523-86200360 18994667002
- sales@pharmahands.com.cn
- Tel
- 13327700685
- sales@vcarepharmatech.com
- Tel
- 025-84767922 18936879710
- sales@abydoscientific.com
- Tel
- 15189849794
- xiaojin.wu@hsdk-pharmatech.cn
(S)-3-(4-(2-Chloro-5-iodobenzyl)phenoxy)tetrahydrofuran(915095-94-2)Related Product Information
- (S)-(5-broMo-2-chlorophenyl)(4-(tetrahydrofuran-3-yloxy)phenyl)Methanone
- (3S,4R)-4-(4-Fluorophenyl)-3-hydroxymethyl-1-methylpiperidine
- Thiazole
- Copper(II) chloride dihydrate
- Tetrahydrofuran
- Dimethyl fumarate
- 1-Propanol
- Brexpiprazole Intermediate 1
- (R)-3-(p-toluenesulfonyl) oxytetrahydrofuran
- Empagliflozin
- (S)-(+)-3-Hydroxytetrahydrofuran
- 4-(5-broMo-2-chlorobenzyl)phenol
- (3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydrofuran
- Benzo[b]thiophene, 2-[(5-broMo-2-fluorophenyl)Methyl]-
- (2-Chloro-5-iodophenyl)[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methanone
- (2S,3R,4S,5S,6R)-2-(3-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)-4-chlorophenyl)-tetrahydro-6-(hydroxyMethyl)-2-Methoxy-2H-pyran-3,4,5-triol
- 2,3,4,6-Tetra-O-benzyl-a-D-glucopyranosylbromide
- (2-Chloro-5-iodophenyl)(4-fluorophenyl)methanone